Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: Comparison of the porcine and rat responses
Janos Szebeni
Journal of Controlled Release, 2014
View PDFchevron_right
Liposome-induced pulmonary hypertension: properties and mechanism of a complement-mediated pseudoallergic reaction
Lajos Baranyi
View PDFchevron_right
Hemodynamic Changes Induced by Liposomes and Liposome-Encapsulated Hemoglobin in Pigs A Model for Pseudoallergic Cardiopulmonary Reactions to Liposomes: Role of Complement and Inhibition by Soluble CR1 and AntiC5a Antibody
Janos Szebeni
2000
View PDFchevron_right
Acute physiological changes caused by complement activators and amphotericin B-containing liposomes in mice
László Dézsi
International Journal of Nanomedicine
View PDFchevron_right
Complement Activation-Related Cardiac Anaphylaxis in Pigs: Role of C5a Anaphylatoxin and Adenosine in Liposome-Induced Abnormalities in ECG and Heart Function
Lajos Baranyi
2005
View PDFchevron_right
Surprising lack of liposome-induced complement activation by artificial 1,3-diamidophospholipids in vitro
Janos Szebeni
Nanomedicine: Nanotechnology, Biology and Medicine, 2015
View PDFchevron_right
Animal Models of Complement-Mediated Hypersensitivity Reactions to Liposomes and Other Lipid-Based Nanoparticles
Janos Szebeni
View PDFchevron_right
Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: Prediction and prevention
Janos Szebeni
Advanced Drug Delivery Reviews, 2011
View PDFchevron_right
Cardiopulmonary and hemodynamic changes in complement activation-related pseudoallergy
Laszlo Rosivall, László Dézsi, Rudolf Urbanics
Health, 2013
View PDFchevron_right
Complement Activation-Related Pathophysiological Changes in Anesthetized Rats: Activator-Dependent Variations of Symptoms and Mediators of Pseudoallergy
Janos Szebeni
Molecules, 2019
View PDFchevron_right
Complement Activation - Related Hypersensitivity Reactions Caused by Pegylated Liposomes Search for an Alternative Long-Circulating Liposome Formulation Without Complement Activation
Lajos Baranyi
2003
View PDFchevron_right
Cerebrovascular Involvement in Liposome—Induced Cardiopulmonary Distress in Pigs
Michael Bodo
Journal of Liposome Research, 2005
View PDFchevron_right
Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil(R)): possible role in hypersensitivity reactions
Janos Szebeni
Annals of Oncology, 2003
View PDFchevron_right
Complement Activation-Related Pseudoallergy Caused by Liposomes, Micellar Carriers of Intravenous Drugs, and Radiocontrast Agents
Rudolf Urbanics
Critical Reviews in Therapeutic Drug Carrier Systems, 2001
View PDFchevron_right
Rodent models of complement activation-related pseudoallergy: Inducers, symptoms, inhibitors and reaction mechanisms
Janos Szebeni
European Journal of Nanomedicine, 2015
View PDFchevron_right
The complement system enhances the clearance of phosphatidylserine (PS)-liposomes in rat and guinea pig
tran huong
International Journal of Pharmaceutics, 2001
View PDFchevron_right
Szebeni_Nanomedicine_2012.pdf
Janos Szebeni
View PDFchevron_right
Complement activation by PEGylated liposomes containing prednisolone
Reka Nemes
European Journal of Pharmaceutical Sciences, 2013
View PDFchevron_right
Potentiation of liposome-induced complement activation by surface-bound albumin
Lajos Baranyi
Biochimica Et Biophysica Acta-biomembranes, 2002
View PDFchevron_right